Page last updated: 2024-10-21

phenanthridone and Heart Disease, Ischemic

phenanthridone has been researched along with Heart Disease, Ischemic in 1 studies

phenanthridone: coal tar derivative; structure given in first source
phenanthridone : A member of the class of phenanthridines that is phenanthridine with an oxo substituent at position 6. A poly(ADP-ribose) polymerase (PARP) inhibitor, it has been shown to exhibit immunosuppressive activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferraris, D1
Ko, YS1
Pahutski, T1
Ficco, RP1
Serdyuk, L1
Alemu, C1
Bradford, C1
Chiou, T1
Hoover, R1
Huang, S1
Lautar, S1
Liang, S1
Lin, Q1
Lu, MX1
Mooney, M1
Morgan, L1
Qian, Y1
Tran, S1
Williams, LR1
Wu, QY1
Zhang, J1
Zou, Y1
Kalish, V1

Other Studies

1 other study available for phenanthridone and Heart Disease, Ischemic

ArticleYear
Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.
    Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14

    Topics: Animals; Aza Compounds; Brain Ischemia; Dogs; Enzyme Inhibitors; Haplorhini; Humans; In Vitro Techni

2003